Your browser is no longer supported. Please, upgrade your browser.
Settings
ACAD ACADIA Pharmaceuticals Inc. daily Stock Chart
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.34 Insider Own0.10% Shs Outstand100.72M Perf Week3.22%
Market Cap3.94B Forward P/E- EPS next Y-1.18 Insider Trans0.00% Shs Float100.41M Perf Month-17.79%
Income-132.90M PEG- EPS next Q-0.39 Inst Own98.30% Short Float13.80% Perf Quarter-7.19%
Sales0.07M P/S58823.49 EPS this Y-115.90% Inst Trans0.95% Short Ratio12.31 Perf Half Y0.49%
Book/sh2.55 P/B15.35 EPS next Y22.40% ROA-42.70% Target Price48.00 Perf Year46.61%
Cash/sh2.69 P/C14.55 EPS next 5Y20.00% ROE-45.10% 52W Range22.04 - 51.99 Perf YTD23.24%
Dividend- P/FCF- EPS past 5Y4.60% ROI-30.10% 52W High-24.74% Beta3.15
Dividend %- Quick Ratio14.10 Sales past 5Y-56.50% Gross Margin- 52W Low77.54% ATR2.56
Employees136 Current Ratio14.10 Sales Q/Q-96.40% Oper. Margin- RSI (14)51.11 Volatility7.02% 7.05%
OptionableYes Debt/Eq0.00 EPS Q/Q2.50% Profit Margin- Rel Volume3.22 Prev Close38.07
ShortableYes LT Debt/Eq0.00 EarningsAug 06 AMC Payout- Avg Volume1.13M Price39.13
Recom1.70 SMA203.55% SMA50-8.28% SMA2005.65% Volume3,618,579 Change2.78%
Aug-27-15Upgrade Piper Jaffray Neutral → Overweight $48
Aug-07-15Reiterated Needham Buy $38 → $49
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
Apr-16-15Initiated Leerink Partners Outperform $48
Mar-12-15Reiterated Needham Buy $40 → $38
Feb-24-15Initiated H.C. Wainwright Buy $50
Feb-06-15Resumed ROTH Capital Buy $42
Dec-22-14Reiterated Needham Buy $26 → $40
Aug-07-13Reiterated Needham Buy $16 → $26
Aug-07-13Reiterated Ladenburg Thalmann Buy $15 → $24
Aug-07-13Downgrade MLV & Co Buy → Hold $18 → $20
Apr-11-13Reiterated Needham Buy $9 → $16
Apr-11-13Reiterated MLV & Co Buy $12.50 → $18
Apr-11-13Reiterated Ladenburg Thalmann Buy $9 → $15
Mar-13-13Reiterated Ladenburg Thalmann Buy $8 → $9
Nov-28-12Reiterated MLV & Co Buy $4.50 → $8.50
Nov-27-12Upgrade Needham Hold → Buy $9
Nov-27-12Reiterated Ladenburg Thalmann Buy $8
Apr-30-12Initiated Ladenburg Thalmann Buy
Sep-01-09Downgrade Citigroup Hold → Sell
Sep-03-15 04:21PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex
12:27PM  Why Parkinson's Disease-Focused ACADIA Pharmaceuticals is Soaring Today at Motley Fool
10:57AM  Acadia Pharmaceuticals (ACAD) Stock Climbs on Drug Application for Parkinson's Treatment at TheStreet
07:15AM  Acadia Pharmaceuticals submits new FDA for Parkinson's psychosis drug at MarketWatch
07:01AM  ACADIA Pharmaceuticals Appoints Steve Davis as Chief Executive Officer Business Wire
07:00AM  ACADIA Pharmaceuticals Submits New Drug Application for NUPLAZID for the Treatment of Parkinsons Disease Psychosis Business Wire
Sep-02-15 01:03PM  XBI Pharmaceutical Valuation Rises on Strong Small-Cap Performance +6.02%
01:02PM  Acadia, Neurocrine, Dyax, and Opko Trade Below 50-Day Moving Average
Aug-27-15 03:06PM  Why Piper Jaffray Is Upgrading Acadia Pharmaceuticals After A 25% Decline
12:06PM  Acadia Pharmaceuticals Fell 19% after Reporting 2Q15 Earnings
06:38AM  ACADIA Pharmaceuticals upgraded by Piper Jaffray
Aug-25-15 11:55AM  Some Pharma Stocks Trade below All Moving Averages in Early August
11:55AM  Pharmaceutical Stocks Affect the iShares NASDAQ Biotechnology ETF
11:55AM  IBB ETF Pounded by Biotech and Pharma Subgroups in Early August
09:17AM  What Are IBB and XBIs Valuations?
Aug-21-15 04:28PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Aug-15-15 01:04PM  ACADIA PHARMACEUTICALS INC Financials
Aug-14-15 09:05AM  What Were the Valuations for IBBs Pharmaceutical Sector?
08:49AM  Why ACADIA Pharmaceuticals (ACAD) Could Be Positioned for a Slump
Aug-13-15 08:52AM  Horizon Pharma Delivers Strong 2Q15 Results
Aug-11-15 08:33AM  This Undervalued Biotech Company Just Filed For FDA Approval and No One Noticed
Aug-08-15 08:10PM  10-Q for ACADIA Pharmaceuticals, Inc. at Company Spotlight
Aug-07-15 02:11PM  Why ACADIA Pharmaceuticals Inc. is Dropping Today at Motley Fool -13.31%
01:27PM  Acadia Pharma May No Longer Be A Buy Ahead Of NDA Filing
Aug-06-15 07:33PM  Acadia reports 2Q loss -5.15%
07:05PM  Edited Transcript of ACAD earnings conference call or presentation 6-Aug-15 9:00pm GMT
05:00PM  ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
04:05PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
04:01PM  ACADIA Pharmaceuticals Reports Second Quarter 2015 Financial Results Business Wire
09:00AM  ACADIA Pharmaceuticals Announces Publication of Data from Its -015 Open Label Safety Study in Parkinsons Disease Psychosis in the Journal of the American Medical Directors Association Business Wire
07:07AM  Q2 2015 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close
Aug-05-15 03:23PM  Why ACADIA Pharmaceuticals Inc Jumped 17% in July at Motley Fool
09:00AM  ACADIA Pharmaceuticals Announces Senior Management Appointments in Manufacturing, Quality, Compliance, Access and Reimbursement and Business Development Business Wire
Jul-30-15 09:00AM  ACADIA Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2015 Business Wire
Jul-13-15 12:28PM  Notable option activity in equities
Jun-26-15 03:31AM  Edited Transcript of ACAD presentation 24-Jun-15 3:00pm GMT
Jun-19-15 04:43PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a
Jun-17-15 09:00AM  ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 24, 2015 Business Wire
Jun-16-15 09:00AM  ACADIA Pharmaceuticals Presents Integrated Data from Its Phase III Program with NUPLAZID (Pimavanserin) for Parkinsons Disease Psychosis at the 19th International Congress of Parkinsons Disease and Movement Disorders Business Wire
May-26-15 09:00AM  ACADIA Pharmaceuticals to Present at the Jefferies 2015 Healthcare Conference on June 2, 2015 Business Wire
May-18-15 01:38PM  Viking Global Liked AIG, Google, Actavis, Illumina And Cheniere Energy Last Quarter
May-09-15 08:09PM  10-Q for ACADIA Pharmaceuticals, Inc. at Company Spotlight
02:00PM  ACADIA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Acadia Pharmaceuticals, Inc. (ACAD) to Contact the Firm Before the Imminent Lead Plaintiff Deadline GlobeNewswire
May-08-15 02:52PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD PR Newswire
01:24PM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 -- ACAD GlobeNewswire
May-07-15 06:24PM  Acadia reports 1Q loss
05:00PM  ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
04:06PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
04:01PM  ACADIA Pharmaceuticals Reports First Quarter 2015 Financial Results Business Wire
07:07AM  Q1 2015 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close
May-06-15 01:14PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ACADIA Pharmaceuticals Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit ACAD GlobeNewswire
09:49AM  ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference on May 13, 2015 at noodls
09:00AM  ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference on May 13, 2015 Business Wire
May-04-15 07:30PM  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of ACADIA Pharmaceuticals Inc. Of Upcoming Deadline Business Wire
Apr-30-15 09:36AM  ACADIA Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2015 at noodls
09:00AM  ACADIA Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2015 Business Wire
Apr-29-15 03:56PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 - ACAD PR Newswire
12:58PM  ALERT: Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against ACADIA Pharmaceuticals Inc. and of the LP Deadline of May 12, 2015 -- ACAD GlobeNewswire
Apr-24-15 05:37PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline -- ACAD GlobeNewswire
Apr-21-15 10:43AM  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Acadia Pharmaceuticals Inc. and a Lead Plaintiff Deadline of May 12, 2015 Business Wire
Apr-20-15 03:54PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In ACADIA Pharmaceuticals Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
03:10PM  Lifshitz & Miller Law Firm Announces Investigation of Acadia Pharmaceuticals Inc., Akorn, Inc., Dover Saddlery, Inc., Excel Trust, Inc., Informatica Corporation, Inogen, Inc. and Zep, Inc. PR Newswire
Apr-16-15 09:39AM  Acadia Will Outperform, Worth $48/Share Says Leerink
Apr-15-15 01:38PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 Business Wire
Apr-14-15 07:33PM  Cramer Remix: This company's worth double at CNBC
Apr-07-15 09:20AM  ACADIA Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference on April 14, 2015 at noodls
09:00AM  ACADIA Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference on April 14, 2015 Business Wire
Apr-06-15 07:58PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ACADIA Pharmaceuticals Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit ACAD GlobeNewswire
12:07PM  Cohen Milstein Sellers & Toll PLLC Announces the Investigation of ACADIA Pharmaceuticals, Inc. GlobeNewswire
10:56AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 -- ACAD GlobeNewswire
Mar-30-15 04:11PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant
Mar-27-15 09:00PM  IMPORTANT ANNOUNCEMENT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Federal Securities Class Action Has Been Filed Against ACADIA Pharmaceuticals Inc. in the United States District Court for the Southern District of Californi GlobeNewswire +5.24%
Mar-26-15 08:28AM  ACADIA Pharmaceuticals Appoints Daniel Soland to Board of Directors at noodls
08:00AM  ACADIA Pharmaceuticals Appoints Daniel Soland to Board of Directors Business Wire
06:05AM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K/A, Change in Directors or Principal Officers
Mar-25-15 05:04PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Change in Directors or -7.28%
03:45PM  Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD): Sabby Capitals Latest Moves in Healthcare Sector at Insider Monkey
01:07PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 - ACAD Marketwired
12:32PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In ACADIA Pharmaceuticals Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Mar-24-15 07:30PM  Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against ACADIA Pharmaceuticals, Inc. -- ACAD GlobeNewswire
Mar-23-15 08:30AM  Hagens Berman Alerts ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD) Investors With Over $100,000 in Losses of May 12th Lead Plaintiff Deadline GlobeNewswire
Mar-20-15 10:00PM  ACADIA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. Business Wire
Mar-19-15 09:30AM  The Zacks Analyst Blog Highlights: Amgen, Regeneron, Nektar, ACADIA and Pharmacyclics - Press Releases
Mar-18-15 12:44PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $50,000 Investing in Acadia Pharmaceuticals, Inc. (ACAD) to Contact the Firm Marketwired
10:49AM  Biotech Stock Roundup: Amgen & Regeneron Shine at ACC, Nektar Drug Disappoints - Analyst Blog
10:00AM  ACADIA Pharmaceuticals Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire
09:45AM  Deadline in Lawsuit for Investors in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Announced by Shareholders Foundation GlobeNewswire
Mar-17-15 08:45PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ACADIA Pharmaceuticals Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- ACAD GlobeNewswire
06:38PM  Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ACADIA Pharmaceuticals Inc. PR Newswire
10:26AM  Morgan & Morgan Announces That a Class Action Lawsuit Was Filed Against ACADIA Pharmaceuticals Inc. -- ACAD GlobeNewswire
Mar-16-15 10:00PM  ACADIA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. -- ACAD GlobeNewswire
07:18PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ACADIA Pharmaceuticals Inc. and Certain Officers -- ACAD GlobeNewswire
02:15PM  INVESTOR ALERT: Investigation of ACADIA Pharmaceuticals Inc. Announced by Glancy Binkow & Goldberg LLP Business Wire
12:28PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ACADIA PHARMACEUTICALS INC. of PENDENCY OF CLASS ACTION Lawsuit and a Lead Plaintiff DEADLINE of May 12, 2015 -- ACAD GlobeNewswire
10:01AM  Acadia Pharmaceuticals Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of Corporate Wrongdoing PR Newswire
09:11AM  Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
Mar-13-15 10:00PM  Robbins Geller Rudman & Dowd LLP Files Class Action Suit against ACADIA Pharmaceuticals Inc. Business Wire
08:48PM  Lightning Round: Time to take profits on this at CNBC
08:14PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of ACADIA Pharmaceuticals Inc. (ACAD) on Behalf of Shareholders PR Newswire
04:25PM  ACADIA Down on Nuplazid NDA Delay and CEO Resignation - Analyst Blog
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. Its lead product candidate is NUPLAZID, which completed the Phase III pivotal trials for the treatment of Parkinson's disease psychosis; is in Phase II study for Alzheimer's disease psychosis; and has completed Phase II trial for the treatment of schizophrenia. It also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Iversen Leslie LDirectorAug 19Option Exercise11.008,50093,50036,127Aug 21 04:26 PM
Iversen Leslie LDirectorAug 19Option Exercise11.008,50093,50036,127Aug 21 04:26 PM
KAPLAN LESTER J PH DDirectorAug 11Option Exercise11.008,50093,50017,000Aug 13 05:10 PM
Iversen Leslie LDirectorJun 01Option Exercise8.8514,127125,02427,627Jun 03 04:04 PM
Hacksell UliCEOFeb 17Option Exercise1.5530,00046,50030,000Feb 19 05:58 PM
Rasmussen TorstenDirectorFeb 17Option Exercise4.9019,84797,20128,347Feb 19 06:00 PM
Hacksell UliCEOFeb 17Sale34.3030,0001,028,868115,549Feb 19 05:58 PM
Rasmussen TorstenDirectorFeb 17Sale35.0519,847695,5448,500Feb 19 06:00 PM
Brege LauraDirectorFeb 11Option Exercise1.7510,00017,50010,000Feb 13 05:57 PM
Brege LauraDirectorFeb 11Sale33.6310,000336,3490Feb 13 05:57 PM
BORER MICHAEL TDirectorJan 15Option Exercise11.8227,973330,59227,973Jan 16 05:52 PM
BORER MICHAEL TDirectorJan 15Sale33.0227,973923,7660Jan 16 05:52 PM
Hacksell UliCEOJan 14Option Exercise2.0030,00060,00030,000Jan 16 05:51 PM
Hacksell UliCEOJan 14Sale33.9830,0001,019,430115,549Jan 16 05:51 PM
GRAY MARY ANNDirectorJan 13Option Exercise11.004,25046,7504,250Jan 15 06:02 PM
Rasmussen TorstenDirectorJan 13Option Exercise11.0611,905131,66720,405Jan 15 06:03 PM
Rasmussen TorstenDirectorJan 13Sale35.0011,905416,6768,500Jan 15 06:03 PM
GRAY MARY ANNDirectorJan 13Sale35.004,250148,7500Jan 15 06:02 PM
Hacksell UliCEODec 15Option Exercise2.0030,00060,00030,000Dec 17 05:37 PM
GRAY MARY ANNDirectorDec 15Option Exercise9.4512,250115,78012,250Dec 17 05:38 PM
Hacksell UliCEODec 15Sale31.0030,000929,916115,549Dec 17 05:37 PM
GRAY MARY ANNDirectorDec 15Sale31.7412,250388,8150Dec 17 05:38 PM
Baity GlennEVP AND GCDec 09Option Exercise1.558,00012,40062,423Dec 10 06:53 PM
Mills RogerEVP, DEVELOPMENT AND CMONov 26Option Exercise0.0025,000043,550Nov 26 06:29 PM
BORER MICHAEL TDirectorNov 26Option Exercise11.0015,000165,00015,000Nov 26 06:29 PM
BORER MICHAEL TDirectorNov 26Sale30.0515,000450,7650Nov 26 06:29 PM
Mills RogerEVP, DEVELOPMENT AND CMONov 26Sale30.0925,000752,26518,550Nov 26 06:29 PM
Hacksell UliCEONov 24Option Exercise2.0030,00060,00030,000Nov 26 06:27 PM
Hacksell UliCEONov 24Sale29.2830,000878,397115,549Nov 26 06:27 PM
Wells William McDowallDirectorNov 21Option Exercise1.365,8107,9025,810Nov 21 07:48 PM
Wells William McDowallDirectorNov 21Sale29.005,810168,4900Nov 21 07:48 PM
Hacksell UliCEOOct 08Option Exercise2.0030,00060,00030,000Oct 10 05:30 PM
Hacksell UliCEOOct 08Sale24.1530,000724,530115,549Oct 10 05:30 PM
Brege LauraDirectorSep 15Option Exercise1.7510,00017,50010,000Sep 16 06:05 PM
Brege LauraDirectorSep 15Sale28.0710,000280,6690Sep 16 06:05 PM
Wells William McDowallDirectorSep 12Option Exercise1.369,19012,4989,190Sep 16 06:04 PM
Wells William McDowallDirectorSep 12Sale29.159,190267,8730Sep 16 06:04 PM
Hacksell UliCEOSep 10Option Exercise2.0030,00060,00030,000Sep 12 05:56 PM
Hacksell UliCEOSep 10Sale27.3630,000820,821115,549Sep 12 05:56 PM